SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-05-002199
Filing Date
2005-11-14
Accepted
2005-11-14 14:36:10
Documents
1
Group Members
CHARLES DAVIDSONJOSEPH JACOBSTHETA INVESTORS LLCWEXFORD SPECTRUM INVESTORS LLC

Document Format Files

Seq Description Document Type Size
1 WEXFORD MANAGEMENT CORP./ CAPITAL LLC - 11/4/05 srz9990696v4.txt SC 13G 25354
  Complete submission text file 0000902664-05-002199.txt   27620
Mailing Address 130 WEST 42ND STREET NEW YORK NY 10036
Business Address 130 WEST 42ND STREET NEW YORK NY 10036 2125544550
JAVELIN PHARMACEUTICALS, INC (Subject) CIK: 0000050710 (see all company filings)

IRS No.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-62367 | Film No.: 051200184
SIC: 2834 Pharmaceutical Preparations

Mailing Address 411 W PUTNAM AVENUE GREENWICH CT 06830
Business Address 411 W PUTNAM AVENUE GREENWICH CT 06830 2038627000
WEXFORD CAPITAL LLC (Filed by) CIK: 0001048462 (see all company filings)

IRS No.: 061442624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G